Chen Lijing, Liao Guoping, Wang Yan, He Shuai, Zhang Zhongyi
Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Zhongguo Zhong Yao Za Zhi. 2011 Jul;36(14):1884-8.
To investigate the effect of Qingkailing injection (QKLI) on complement and RBL-2 H3 cells in virto.
The mixture of human serums and QKLI were incubated for 30 min in vitro and then the content of SC5 b-9 in the mixture was determined by ELISA. RBL-2 H3 cells were cultured and treated by QKLI. Beta-heosaminidase release rate was measured by coloration method. The content of histamine in supernatant was tested by ELISA.
The QKLI can reduce the content of SC5 b-9 (P<0.05) and promote the release of beta-heosaminidase and histamine significantly (P<0.05).
QKLI didn't induce the complement activation, but induced the release of beta-heosaminidase and histamine directly. Therefore, the clinical adverse reactions of QKLI in clinic may be pseudoallergy which had no relation with the activation of complement system.
体外研究清开灵注射液(QKLI)对补体及RBL - 2H3细胞的影响。
人血清与QKLI混合液在体外孵育30分钟,然后用ELISA法测定混合液中SC5b - 9的含量。培养RBL - 2H3细胞并用QKLI处理。用比色法测定β - 己糖胺酶释放率。用ELISA法检测上清液中组胺的含量。
QKLI可降低SC5b - 9的含量(P<0.05),并显著促进β - 己糖胺酶和组胺的释放(P<0.05)。
QKLI不诱导补体激活,但直接诱导β - 己糖胺酶和组胺的释放。因此,QKLI在临床上的不良反应可能是假性过敏,与补体系统激活无关。